secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0000950170-24-070569
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics CMO Dr. Norman LaFrance resigns effective June 12, 2024
-------------------------------------------------------------------------

- Dr. Norman LaFrance resigned as Chief Medical Officer on June 5, 2024.
- Resignation effective June 12, 2024; no reason provided in the filing.
- No successor or interim CMO announced; President & CEO Marc Hedrick signs 8-K.
- Company trades on Nasdaq under ticker PSTV.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000095017024070569/0000950170-24-070569-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000095017024070569/pstv-20240605.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-070569

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer